Review



pu 1 inhibitor db1976 dihydrochloride  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress pu 1 inhibitor db1976 dihydrochloride
    Pu 1 Inhibitor Db1976 Dihydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pu+1+inhibitor+db1976/DB1976+dihydrochloride/pm40769342-102-14-21
    Average 94 stars, based on 8 article reviews
    pu 1 inhibitor db1976 dihydrochloride - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Activity Assay:

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20 μM, MCE) and the PU.1 inhibitor DB1976 (100 nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases.
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20μM,MCE) and the PU.1 inhibitor DB1976 (100nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.

    Binding Assay:

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20 μM, MCE) and the PU.1 inhibitor DB1976 (100 nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases.
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20μM,MCE) and the PU.1 inhibitor DB1976 (100nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.

    Footprinting:

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20 μM, MCE) and the PU.1 inhibitor DB1976 (100 nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4 − ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases.
    Article Snippet: Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.Afterwards, flow cytometry was conducted to analyze the expression of TLR4, phosphorylated(p)-c-Fos, p-Jun, and PU.1 in the ILC2s.. To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20μM,MCE) and the PU.1 inhibitor DB1976 (100nM, MCE) for 1 h prior to stimulation.. To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.To generate in vitro-trained ILC2s, TLR4−ILC2s were isolated from IL-33 challenged WT C57BL/6 J mice.



    Similar Products

    pu 1 inhibitor db1976 dihydrochloride  (MedChemExpress)
    94
    MedChemExpress pu 1 inhibitor db1976 dihydrochloride
    Pu 1 Inhibitor Db1976 Dihydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pu+1+inhibitor+db1976/DB1976+dihydrochloride/pm40769342-102-14-21
    Average 94 stars, based on 1 article reviews
    pu 1 inhibitor db1976 dihydrochloride - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    db1976  (MedChemExpress)
    94
    MedChemExpress db1976
    Db1976, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pu+1+inhibitor+db1976/DB1976/custom%40hy-135797a%4040769342
    Average 94 stars, based on 1 article reviews
    db1976 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    pu 1 inhibitor db1976  (MedChemExpress)
    94
    MedChemExpress pu 1 inhibitor db1976
    A Schematic diagram of the experimental study design for scATAC-seq of lung tissues from wide-type HDM sensitized mice. B Uniform manifold approximation and projection (UMAP) plots of sorted viable CD45 + Lin ⁻ ICOS + ST2 + cells from HDM-sensitized mice at day 45 and day 47. Each dot represents a single cell, with different ILC2 subsets shown in different colors. C Alteration of chromatin accessibility in the ILC2_c02 subset at day 47 versus day 45. The Y axis presents the log2 fold change of gene activity at day 47 versus day 45 and in library 2, while the X axis shows the log2 fold change in library 1. D Transcription factor binding motifs significantly enriched in the ILC2_c02 subset at day 47 versus day 45. P- values were calculated by a right-tailed hypergeometric test. E DNA accessibility tracing of the Tlr4 and Il1rl1 of different ILC2 subsets. Shaded boxes delineate increased chromatin accessibility. F Predicted motifs within Tlr4 promoter. G Motif footprinting trace showing binding activities of transcription factor JunB, <t>Fos,</t> <t>PU.1</t> and MafK.
    Pu 1 Inhibitor Db1976, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pu+1+inhibitor+db1976/DB1976+dihydrochloride/pmc12318100-334-31-36
    Average 94 stars, based on 1 article reviews
    pu 1 inhibitor db1976 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    pu 1 inhibitor  (MedChemExpress)
    94
    MedChemExpress pu 1 inhibitor
    A Schematic diagram of the experimental study design for scATAC-seq of lung tissues from wide-type HDM sensitized mice. B Uniform manifold approximation and projection (UMAP) plots of sorted viable CD45 + Lin ⁻ ICOS + ST2 + cells from HDM-sensitized mice at day 45 and day 47. Each dot represents a single cell, with different ILC2 subsets shown in different colors. C Alteration of chromatin accessibility in the ILC2_c02 subset at day 47 versus day 45. The Y axis presents the log2 fold change of gene activity at day 47 versus day 45 and in library 2, while the X axis shows the log2 fold change in library 1. D Transcription factor binding motifs significantly enriched in the ILC2_c02 subset at day 47 versus day 45. P- values were calculated by a right-tailed hypergeometric test. E DNA accessibility tracing of the Tlr4 and Il1rl1 of different ILC2 subsets. Shaded boxes delineate increased chromatin accessibility. F Predicted motifs within Tlr4 promoter. G Motif footprinting trace showing binding activities of transcription factor JunB, <t>Fos,</t> <t>PU.1</t> and MafK.
    Pu 1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pu+1+inhibitor+db1976/DB1976/pm37749326-305-8-11
    Average 94 stars, based on 1 article reviews
    pu 1 inhibitor - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    A Schematic diagram of the experimental study design for scATAC-seq of lung tissues from wide-type HDM sensitized mice. B Uniform manifold approximation and projection (UMAP) plots of sorted viable CD45 + Lin ⁻ ICOS + ST2 + cells from HDM-sensitized mice at day 45 and day 47. Each dot represents a single cell, with different ILC2 subsets shown in different colors. C Alteration of chromatin accessibility in the ILC2_c02 subset at day 47 versus day 45. The Y axis presents the log2 fold change of gene activity at day 47 versus day 45 and in library 2, while the X axis shows the log2 fold change in library 1. D Transcription factor binding motifs significantly enriched in the ILC2_c02 subset at day 47 versus day 45. P- values were calculated by a right-tailed hypergeometric test. E DNA accessibility tracing of the Tlr4 and Il1rl1 of different ILC2 subsets. Shaded boxes delineate increased chromatin accessibility. F Predicted motifs within Tlr4 promoter. G Motif footprinting trace showing binding activities of transcription factor JunB, Fos, PU.1 and MafK.

    Journal: Nature Communications

    Article Title: TLR4 + group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases

    doi: 10.1038/s41467-025-62532-0

    Figure Lengend Snippet: A Schematic diagram of the experimental study design for scATAC-seq of lung tissues from wide-type HDM sensitized mice. B Uniform manifold approximation and projection (UMAP) plots of sorted viable CD45 + Lin ⁻ ICOS + ST2 + cells from HDM-sensitized mice at day 45 and day 47. Each dot represents a single cell, with different ILC2 subsets shown in different colors. C Alteration of chromatin accessibility in the ILC2_c02 subset at day 47 versus day 45. The Y axis presents the log2 fold change of gene activity at day 47 versus day 45 and in library 2, while the X axis shows the log2 fold change in library 1. D Transcription factor binding motifs significantly enriched in the ILC2_c02 subset at day 47 versus day 45. P- values were calculated by a right-tailed hypergeometric test. E DNA accessibility tracing of the Tlr4 and Il1rl1 of different ILC2 subsets. Shaded boxes delineate increased chromatin accessibility. F Predicted motifs within Tlr4 promoter. G Motif footprinting trace showing binding activities of transcription factor JunB, Fos, PU.1 and MafK.

    Article Snippet: To confirm the role of transcriptional factor in induction of TLR4 on ILC2s, the ILC2s were pre-treated with the transcription factor c-Fos / AP-1 inhibitor T-5224 (20 μM, MCE) and the PU.1 inhibitor DB1976 (100 nM, MCE) for 1 h prior to stimulation.

    Techniques: Activity Assay, Binding Assay, Footprinting